key: cord-0934985-19sds4nr authors: Heuts, Samuel; Ubben, Johannes F.; Banks-Gonzales, Vanessa; Sels, Jan-Willem; Lorusso, Roberto; van Mook, Walther N.K.A.; Delnoij, Thijs S.R. title: Nitric oxide ventilation improves recirculation and right ventricular function during veno-venous extracorporeal membrane oxygenation in a COVID-19 patient date: 2020-10-05 journal: J Cardiothorac Vasc Anesth DOI: 10.1053/j.jvca.2020.09.137 sha: 2f583b08a65d1f31cf8e0f67f16af282db09c352 doc_id: 934985 cord_uid: 19sds4nr COVID-19 patients are prone to pulmonary artery hypertension (PAH) and right ventricular pressure overload due to severe bilateral infiltrates, high ventilation pressures, persistent hypoxemia, pulmonary fibrosis and/or pulmonary embolism. In patients on extra-corporeal membrane oxygenation (ECMO), this potentially leads to increased recirculation. In the current report, we present a case in which continuous inhaled nitric oxide (iNO)-enriched ventilation was effective in terms of PAH and recirculation reduction in a COVID-19 patient on veno-venous ECMO. Before considering initiation of V-V ECMO, guidelines recommend the use of salvage techniques such as prone positioning and administration of neuromuscular blocking agents 3, 4 . Additionally, these guidelines mention the use of inhaled pulmonary vasodilators as potential alternative options. In these cases, Pulmonary vasodilators could be beneficial in some patients through a reduction of pulmonary pressures and an improvement in ventilationperfusion match, through their vasodilatory effect 5 . The class IIb recommendation is however supported by a low quality level of evidence 3 . In the current report, the case of a COVID-19 patient with severe ARDS on V-V ECMO is presented, in which iNO had a beneficial effect on pulmonary hypertension and ECMO recirculation. A 45-year old male, with an unremarkable history, presented to a regional hospital's emergency department with progressive dyspnea for 3 weeks. position on TTE and chest/abdominal X-ray ( Figure 1 ). We concluded that RV pressure overload and TR caused backflow of oxygenated ECMO blood and increased recirculation. To reduce pulmonary vascular resistance, first an aerosolized prostacyclin analogue was administered at an initial dose of 2.5mcg and a second dose of 5.0mcg (iloprost-trometamol, 20mcg/ml, Ventavis, Bayer, Germany), with a limited effect. After treatment effect of iloprost ceased, continuous iNO was initiated (starting dose 20ppm, dose increase to 30ppm), followed by a remarkable pO 2 increase after which oxygenation remained stable (Table 1, Figure 2 ). Direct follow-up TTE showed a significant reduction in RV dimensions with good contractility, no residual TR and a significant reduction of blood recirculation (33%). Moreover, recirculation improved to 22% after 24 hours (Table 1) . Cardiac output improved the morning after to 7.5L/min with an increase in mean arterial blood pressure from 62mmHg to 80mmHg) After initial respiratory improvement, the clinical course was however again complicated by superinfection with refractory multi-organ failure, which proved non-responsive to maximal supportive therapy, after which treatment was ceased, without considering a conversion to alternative ECMO configurations, due to a futile prognosis. COVID-19 can cause severe ARDS for which V-V ECMO can be used as a lifesaving treatment modality. Currently, 44% of V-V ECMO COVID-19 patients survive until discharge 9 , which is comparable to patients with severe ARDS in the EOLIA-trial 10 . The effectiveness of ECMO treatment is dependent on a variety of patient and therapy-related factors, including ECMO blood flow, patient cardiac output, metabolic demand, oxygenator membrane performance and the amount of recirculation within the ECMO circuit 11 . The work-up of hypoxemia during V-V ECMO is therefore complicated and requires a structured approach, which is presented in the flow-chart in Figure 3 . In the femoral-to-jugular vein configuration (Vf-Vj), a closer proximity of the inferior to the superior caval vein cannula can induce a marked recirculation. Additionally, increased RV end-diastolic filling pressures and subsequent TR can re-direct infused blood flow towards the drainage cannula, increasing the blood recirculation fraction. RV failure secondary to pulmonary artery hypertension (PAH) is commonly seen in ARDS and has a multifactorial etiology in general 12 , and may be precipitated by pulmonary emboli and/or fibrosis in COVID-19 patients in particular 13, 14 . In such cases, a switch to a veno-arterial configuration can be considered, although this could potentially lead to differential hypoxemia (also known as Harlequin's syndrome or North/South syndrome) when using a peripheral approach. Alternatively, a veno-arterial/venous configuration could support the RV in specific cases of refractory RV failure and avoid differential oxygenation 15, 16 . It was opted to improve the recirculation fraction by reducing PH and subsequent TR pharmacologically. In current guidelines, iloprost is prescribed 6-9 times per day, while it has a relatively short half-life (15-30 minutes) and short working period 17 Venovenous Extracorporeal Membrane Oxygenation in Intractable Pulmonary Insufficiency: Practical Issues and Future Directions Extracorporeal life support: experience with 2,000 patients Management of Critically Ill Adults With COVID-19 Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome The Extracorporeal Life Support Organization Maastricht Treaty for Nomenclature in Extracorporeal Life Support. A Position Paper of the Extracorporeal Life Support Organization Use of dilutional ultrasound monitoring to detect changes in recirculation during venovenous extracorporeal membrane oxygenation in swine Recirculation during veno-venous extracorporeal membrane oxygenation--a simulation study Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Recirculation in venovenous extracorporeal membrane oxygenation Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact Incidence of thrombotic complications in critically ill ICU patients with COVID-19 COVID-19): a pictorial review Pulmonary artery cannulation to enhance extracorporeal membrane oxygenation management in acute cardiac failure Right ventricular dysfunction during acute respiratory distress syndrome and veno-venous extracorporeal membrane oxygenation Inhaled iloprost for the treatment of pulmonary hypertension A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy Inhaled bronchodilator therapy in mechanically ventilated patients Aerosol Deposition in the Human Lung at Variable Tidal Volumes: Calculation of Fractional Deposition Axial computed tomography images demonstrating typical features of bilateral COVID-19 pneumonia and absence of pulmonary emboli None. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. None declared.